Lee, Eunmi
Tao, Yujie
Wang, Alice J. https://orcid.org/0009-0000-6665-3715
Kang, Yibin https://orcid.org/0000-0002-1626-6730
Funding for this research was provided by:
Ludwig Institute for Cancer Research (NA)
Article History
Received: 19 December 2025
Revised: 25 April 2026
Accepted: 29 April 2026
First Online: 3 August 2026
Ethics
Competing interests: Y.K. holds equity interest and serves as the Chair of the Scientific Advisory Boards of KayoThera, Inc. and Firebrand Therapeutics, Inc. The other authors declare no competing interests.